<DOC>
	<DOCNO>NCT03051698</DOCNO>
	<brief_summary>The purpose proof-of-concept study determine effect Intestinal Microbiota Depletion Intravenous Administration C1-inhibitor Inflammation Coagulation Bronchial Instillation House Dust Mite Allergen Lipopolysaccharide Allergic Asthma Patients</brief_summary>
	<brief_title>C1-inhibitor Allergic ASThma Patients</brief_title>
	<detailed_description>Intravenous administration C1-inhibitor ( n=20 ) vehicle ( n=20 ) . One group patient ( n=20 ) receive broad spectrum antibiotic ( vancomycin , ciprofloxacin , metronidazole ) 7 day ( washout 36 hour study day ) . This group receive vehicle control group 2 hour prior challenge . HDM administer together environmental pollutant LPS lung subsegment via bronchoscope ( mimic environmental exposure HDM ) ; contralateral lung subsegment administer saline ( control side ) . After 7 hour , bronchoalveolar lavage ( BAL ) fluid harvest second bronchoscopy . Blood sample collect administration C1-inhibitor vehicle , bronchoscopies . Faeces collect prior antibiotic administration well prior HDM+LPS challenge .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<mesh_term>Complement C1 Inactivator Proteins</mesh_term>
	<criteria>Intermittent mild asthma accord Global Initiative Asthma ( GINA ) criteria Allergy HDM document positive RAST positive skin prick test . No clinically significant finding physical examination hematological biochemical screening At spirometry FEV1 70 % predict value A PC20 0.3 9.6 mg/ml ( correspond increase airway hyperreactivity ) Able communicate well investigator comply requirement study Stable asthma without use asthma medication 2 week prior study day . As documented Juniper 's Asthma control questionnaire ( ACQ ) score &lt; 1,2 . Written inform consent No current smoking least 1 year le 10 pack year smoke history Relevant comorbidity , pregnancy and/or recent surgical procedure . A history smoking within last 12 month , regular consumption great three unit alcohol per day Exacerbation and/ use asthma medication within 2 week start Administration investigational drug within 30 day study initiation Donation blood within 60 day , loss great 400 ml blood within 12 week study initiation ] History venous arterial thromboembolic disease History enhance bleed tendency abnormal clot test result . History serious drugrelated reaction , include hypersensitivity Inability maintain stable without use asthma medication 2 week start study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>C1-inhibitor</keyword>
	<keyword>house dust mite</keyword>
	<keyword>complement system</keyword>
</DOC>